Suppr超能文献

豚鼠肾脏25-羟基维生素D-3 1α-羟化酶:发育和孕期的活性变化

Renal 25-hydroxyvitamin D-3 1 alpha-hydroxylase in guinea-pig: activity variations during development and pregnancy.

作者信息

Hagenfeldt Y, Björkhem I, Eriksson H

机构信息

Department of Clinical Chemistry, Karolinska Institutet, Huddinge Hospital, Sweden.

出版信息

Biochim Biophys Acta. 1990 Jan 16;1042(1):94-8. doi: 10.1016/0005-2760(90)90061-2.

Abstract

The renal 25-hydroxyvitamin D-3-1 alpha-hydroxylase (1 alpha-hydroxylase) activity and circulating levels of 1,25-dihydroxyvitamin D (1,25(OH)2D) were measured in pregnant guinea-pigs and their offspring. Serum levels of 1,25(OH)2D were significantly elevated in pregnant guinea-pigs but the renal enzyme activity was not different from non-pregnant animals. The fetal renal 1 alpha-hydroxylase activity was about 6-fold higher than the maternal level, whereas circulating 1,25(OH)2D was low. Treatment with pharmacological doses of 1,25(OH)2D3 increased circulating 1,25(OH)2D and depressed the renal 1 alpha-hydroxylases both in the mother and the fetus. In newborn guinea-pigs the enzyme activity was up to 10-times that seen in adults. It declined over the first 3 weeks, showing no difference between the sexes. In sexually mature animals the males had a significantly higher 1 alpha-hydroxylase activity than the female. However, this higher enzyme activity was not correlated to serum testosterone. Around the time the animals reached sexual maturity serum 1,25(OH)2D increased in both sexes. In the males this rise was correlated to an increase in serum testosterone. It is concluded that the maternal renal 1 alpha-hydroxylase activity is unchange in late pregnancy, compared to non-pregnant females. The data indicate that the fetus produces 1,25(OH)2D, and may contribute to the maternal circulating 1,25(OH)2D. The sex difference in 1 alpha-hydroxylase activity previously demonstrated is manifest at about the time of puberty.

摘要

对怀孕豚鼠及其后代的肾脏25-羟维生素D-3-1α-羟化酶(1α-羟化酶)活性和循环中的1,25-二羟维生素D(1,25(OH)₂D)水平进行了测量。怀孕豚鼠血清中的1,25(OH)₂D水平显著升高,但肾脏酶活性与未怀孕动物并无差异。胎儿肾脏的1α-羟化酶活性比母体水平高约6倍,而循环中的1,25(OH)₂D水平较低。用药理剂量的1,25(OH)₂D₃治疗会使母体和胎儿循环中的1,25(OH)₂D升高,并抑制肾脏1α-羟化酶。新生豚鼠的酶活性高达成年豚鼠的10倍。在出生后的前3周,酶活性下降,且雌雄之间无差异。在性成熟动物中,雄性的1α-羟化酶活性显著高于雌性。然而,这种较高的酶活性与血清睾酮无关。在动物达到性成熟时,雌雄两性的血清1,25(OH)₂D均升高。在雄性中,这种升高与血清睾酮的增加相关。结论是,与未怀孕的雌性相比,怀孕后期母体肾脏的1α-羟化酶活性没有变化。数据表明,胎儿能够产生1,25(OH)₂D,并可能对母体循环中的1,25(OH)₂D有贡献。先前证明的1α-羟化酶活性的性别差异在青春期左右表现出来。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验